DK0817637T3 - Synergistiske kombinationer af zidovudin, 1592U89 og 3TC eller FTC - Google Patents

Synergistiske kombinationer af zidovudin, 1592U89 og 3TC eller FTC

Info

Publication number
DK0817637T3
DK0817637T3 DK96911953T DK96911953T DK0817637T3 DK 0817637 T3 DK0817637 T3 DK 0817637T3 DK 96911953 T DK96911953 T DK 96911953T DK 96911953 T DK96911953 T DK 96911953T DK 0817637 T3 DK0817637 T3 DK 0817637T3
Authority
DK
Denmark
Prior art keywords
ftc
zidovudine
synergistic combinations
synergistic
combinations
Prior art date
Application number
DK96911953T
Other languages
Danish (da)
English (en)
Inventor
Clair Martha Heider St
David Walter Barry
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26306774&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0817637(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9506489.5A external-priority patent/GB9506489D0/en
Priority claimed from GBGB9506490.3A external-priority patent/GB9506490D0/en
Application filed by Wellcome Found filed Critical Wellcome Found
Application granted granted Critical
Publication of DK0817637T3 publication Critical patent/DK0817637T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicinal Preparation (AREA)
DK96911953T 1995-03-30 1996-03-28 Synergistiske kombinationer af zidovudin, 1592U89 og 3TC eller FTC DK0817637T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9506489.5A GB9506489D0 (en) 1995-03-30 1995-03-30 Antiviral combinations
GBGB9506490.3A GB9506490D0 (en) 1995-03-30 1995-03-30 Antiviral combinations
PCT/EP1996/001352 WO1996030025A1 (fr) 1995-03-30 1996-03-28 Combinaisons synergiques de zidovudine, 1592u89 et 3tc ou ftc

Publications (1)

Publication Number Publication Date
DK0817637T3 true DK0817637T3 (da) 2002-11-11

Family

ID=26306774

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96911953T DK0817637T3 (da) 1995-03-30 1996-03-28 Synergistiske kombinationer af zidovudin, 1592U89 og 3TC eller FTC

Country Status (36)

Country Link
US (1) US6417191B1 (fr)
EP (1) EP0817637B1 (fr)
JP (1) JP2954357B2 (fr)
KR (1) KR100542536B1 (fr)
CN (1) CN1103593C (fr)
AP (1) AP652A (fr)
AT (1) ATE220551T1 (fr)
AU (1) AU715213B2 (fr)
BR (3) BRPI9612992B1 (fr)
CA (1) CA2216634C (fr)
CZ (1) CZ295940B6 (fr)
DE (3) DE69622386T2 (fr)
DK (1) DK0817637T3 (fr)
EA (1) EA000626B3 (fr)
EE (1) EE04047B1 (fr)
ES (1) ES2179193T3 (fr)
FR (1) FR05C0022I2 (fr)
GE (1) GEP20022647B (fr)
HK (1) HK1009401A1 (fr)
HU (1) HU224010B1 (fr)
IL (1) IL117727A (fr)
LU (1) LU91171I2 (fr)
MX (1) MX9707316A (fr)
MY (1) MY115461A (fr)
NL (1) NL300195I2 (fr)
NO (2) NO313787B1 (fr)
NZ (1) NZ306419A (fr)
OA (1) OA10616A (fr)
PL (1) PL187085B1 (fr)
PT (1) PT817637E (fr)
RO (1) RO117995B1 (fr)
SI (1) SI0817637T1 (fr)
SK (1) SK283825B6 (fr)
TR (1) TR199701074T1 (fr)
UA (1) UA60293C2 (fr)
WO (1) WO1996030025A1 (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0938321B1 (fr) * 1996-06-25 2004-01-14 Glaxo Group Limited Combinaisons comprenant du vx478, de la zidovudine et du 3tc pouvant etre utilisees dans le traitement du vih
US6113920A (en) * 1996-10-31 2000-09-05 Glaxo Wellcome Inc. Pharmaceutical compositions
TW536403B (en) * 1997-03-24 2003-06-11 Glaxo Group Ltd An ethanol and ethylenediaminetetraacetic acid free pharmaceutical composition comprising lamivudine and exhibiting antimicrobial preservative efficacy
GB9709945D0 (en) * 1997-05-17 1997-07-09 Glaxo Group Ltd A novel salt
AU769660B2 (en) * 1997-05-17 2004-01-29 Glaxo Group Limited Carbocyclic nucleoside hemisulfate and its use in treating viral infections
AU7912398A (en) * 1997-05-17 1998-12-11 Glaxo Group Limited Antiviral combinations containing the carbocyclic nucleoside 1592u89
GB9809213D0 (en) * 1998-04-29 1998-07-01 Glaxo Group Ltd Pharmaceutical compositions
US6875773B1 (en) 1998-05-29 2005-04-05 Ben M. Dunn Combination therapy for treatment of FIV infection
AU4219799A (en) * 1998-05-29 1999-12-13 University Of Florida Combination therapy for treatment of fiv infection
GB9820417D0 (en) * 1998-09-18 1998-11-11 Glaxo Group Ltd Antiviral combinations
US6432966B2 (en) 1999-10-29 2002-08-13 Smithkline Beecham Corporation Antiviral combinations
US7074417B2 (en) * 2000-10-13 2006-07-11 Advancis Pharmaceutical Corporation Multiple-delayed release anti-viral product, use and formulation thereof
AP2220A (en) * 2001-05-11 2011-03-24 Cipla Medpro Pty Ltd Pharmaceutical composition.
TW200403061A (en) * 2002-06-04 2004-03-01 Glaxo Group Ltd Pharmaceutical compositions
AU2004206821C1 (en) 2003-01-14 2009-10-01 Gilead Sciences, Inc. Compositions and methods for combination antiviral therapy
CN100469769C (zh) 2003-03-24 2009-03-18 弗·哈夫曼-拉罗切有限公司 作为逆转录酶抑制剂的苄基-哒嗪酮
DE602004030369D1 (de) 2003-10-24 2011-01-13 Immunaid Pty Ltd Therapieverfahren
TWI471145B (zh) 2005-06-13 2015-02-01 Bristol Myers Squibb & Gilead Sciences Llc 單一式藥學劑量型
EP1940781A1 (fr) 2005-10-19 2008-07-09 F.Hoffmann-La Roche Ag Phénylacétamides en tant qu'inhibiteurs de nnrt
WO2008071587A2 (fr) 2006-12-13 2008-06-19 F. Hoffmann-La Roche Ag Inhibiteurs non nucléosidiques de la transcriptase inverse
PL2120878T3 (pl) * 2007-02-09 2015-01-30 Alphapharm Pty Ltd Postać dawkowania zawierająca dwa czynne składniki farmaceutyczne o różnych postaciach fizycznych
DK2435825T3 (en) 2009-05-27 2015-10-19 Biotempus Ltd Modes for medical care
TR201807704T4 (tr) 2010-01-27 2018-06-21 Viiv Healthcare Co Anti-viral tedavi.
EP3038607A2 (fr) 2013-08-29 2016-07-06 Teva Pharmaceutical Industries Ltd. Forme pharmaceutique unitaire comprenant de l'emtricitabine, du ténofovir, du darunavir et du ritonavir et un comprimé monolithique comprenant du darunavir et du ritonavir
TW201622731A (zh) 2014-04-08 2016-07-01 泰瓦藥品工業有限公司 包含恩曲他濱（Ｅｍｔｒｉｃｉｔａｂｉｎｅ）、替諾福韋（Ｔｅｎｏｆｏｖｉｒ）、地瑞那韋（Ｄａｒｕｎａｖｉｒ）及利托那韋（Ｒｉｔｏｎａｖｉｒ）之單位劑型以及包含地瑞那韋及利托那韋之單層錠劑
CN117088931A (zh) 2014-08-12 2023-11-21 莫纳什大学 定向淋巴的前药
WO2017041139A1 (fr) 2015-09-08 2017-03-16 Monash University Promédicaments ciblant la lymphe
WO2019046491A1 (fr) * 2017-08-29 2019-03-07 Ariya Therapeutics, Inc. Promédicaments lipidiques orientant vers le système lymphatique
US11883497B2 (en) 2017-08-29 2024-01-30 Puretech Lyt, Inc. Lymphatic system-directing lipid prodrugs
US11608345B1 (en) 2017-12-19 2023-03-21 Puretech Lyt, Inc. Lipid prodrugs of rapamycin and its analogs and uses thereof
US11304954B2 (en) 2017-12-19 2022-04-19 Puretech Lyt, Inc. Lipid prodrugs of mycophenolic acid and uses thereof
CA3166908A1 (fr) 2020-02-05 2021-08-12 Daniel Kenneth BONNER Promedicaments lipidiques de neurosteroides

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4724232A (en) * 1985-03-16 1988-02-09 Burroughs Wellcome Co. Treatment of human viral infections
US5047407A (en) 1989-02-08 1991-09-10 Iaf Biochem International, Inc. 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
US5122517A (en) 1988-06-10 1992-06-16 Regents Of The University Of Minnesota Antiviral combination comprising nucleoside analogs
GB8815265D0 (en) * 1988-06-27 1988-08-03 Wellcome Found Therapeutic nucleosides
US5204466A (en) 1990-02-01 1993-04-20 Emory University Method and compositions for the synthesis of bch-189 and related compounds
GB9009861D0 (en) 1990-05-02 1990-06-27 Glaxo Group Ltd Chemical compounds
GB9104740D0 (en) * 1991-03-06 1991-04-17 Wellcome Found Antiviral nucleoside combination
DK0513917T4 (da) 1991-05-16 2001-06-25 Glaxo Group Ltd Antivirale kombinationer indeholdende nukleosidanaloger
ATE184787T1 (de) * 1992-05-13 1999-10-15 Wellcome Found Therapeutische kombinationen
US5723490A (en) 1992-09-08 1998-03-03 Vertex Pharmaceuticals Incorporated THF-containing sulfonamide inhibitors of aspartyl protease
GB9417249D0 (en) 1994-08-26 1994-10-19 Wellcome Found A novel salt
US5869461A (en) 1995-03-16 1999-02-09 Yale University Reducing toxicity of L-nucleosides with D-nucleosides
EP0938321B1 (fr) 1996-06-25 2004-01-14 Glaxo Group Limited Combinaisons comprenant du vx478, de la zidovudine et du 3tc pouvant etre utilisees dans le traitement du vih
TR199802703T2 (xx) 1996-06-25 1999-03-22 Glaxo Group Limited HIV tedavisinde Vx478, Zidov�din, ve/veya 1592U89 i�eren kombinasyonlar�n kullan�m�.
DE10226522A1 (de) * 2002-06-14 2003-12-24 Degussa Verwendung von Übergangsmetallkomplexen mit stickstoffhaltigen mehrzähnigen Liganden als Bleichkatalysator und Bleichmittelzusammensetzung

Also Published As

Publication number Publication date
EE9700240A (et) 1998-04-15
CA2216634C (fr) 2004-07-20
NO2005014I2 (no) 2008-02-11
DE69622386D1 (de) 2002-08-22
HUP9801571A2 (hu) 1999-01-28
JPH10511682A (ja) 1998-11-10
DE122005000029I1 (de) 2005-10-06
NL300195I1 (nl) 2005-08-01
TR199701074T1 (xx) 1998-02-21
CZ309097A3 (cs) 1998-05-13
BRPI9607851B8 (pt) 2019-11-05
ATE220551T1 (de) 2002-08-15
BR9607851B1 (pt) 2009-01-13
OA10616A (en) 2001-03-15
BR9607851A (pt) 1998-07-21
CZ295940B6 (cs) 2005-12-14
JP2954357B2 (ja) 1999-09-27
PL187085B1 (pl) 2004-05-31
NO2005014I1 (no) 2005-06-06
FR05C0022I1 (fr) 2005-06-10
HU224010B1 (hu) 2005-04-28
LU91171I2 (fr) 2005-07-04
NL300195I2 (nl) 2005-11-01
NO974510D0 (no) 1997-09-29
EE04047B1 (et) 2003-06-16
NO313787B1 (no) 2002-12-02
EA199700203A1 (ru) 1998-02-26
SK283825B6 (sk) 2004-02-03
WO1996030025A1 (fr) 1996-10-03
RO117995B1 (ro) 2002-12-30
PL322532A1 (en) 1998-02-02
EA000626B1 (ru) 1999-12-29
KR100542536B1 (ko) 2006-03-23
KR19980703420A (ko) 1998-11-05
AP652A (en) 1998-06-19
IL117727A (en) 1999-11-30
AU5497296A (en) 1996-10-16
CN1185110A (zh) 1998-06-17
MX9707316A (es) 1997-11-29
BRPI9612992B1 (pt) 2020-08-04
HUP9801571A3 (en) 2001-04-28
NO974510L (no) 1997-09-29
UA60293C2 (uk) 2003-10-15
SI0817637T1 (en) 2002-10-31
MY115461A (en) 2003-06-30
CN1103593C (zh) 2003-03-26
HK1009401A1 (en) 1999-09-10
SK129597A3 (en) 1998-07-08
FR05C0022I2 (fr) 2005-10-21
US6417191B1 (en) 2002-07-09
IL117727A0 (en) 1996-07-23
GEP20022647B (en) 2002-03-25
CA2216634A1 (fr) 1996-10-03
LU91171I9 (fr) 2018-12-28
EP0817637A1 (fr) 1998-01-14
AP9701089A0 (en) 1997-10-31
NZ306419A (en) 2000-01-28
PT817637E (pt) 2002-11-29
DE122005000029I2 (de) 2006-04-27
DE69622386T2 (de) 2003-02-13
AU715213B2 (en) 2000-01-20
EP0817637B1 (fr) 2002-07-17
EA000626B3 (ru) 2016-04-29
ES2179193T3 (es) 2003-01-16

Similar Documents

Publication Publication Date Title
DK0817637T3 (da) Synergistiske kombinationer af zidovudin, 1592U89 og 3TC eller FTC
DK1021410T3 (da) Prostaglandinagonister og deres anvendelse til behandling af knogletilstande
NO983965D0 (no) Polymer-organoleire-kompositter og deres fremstilling
NO972983D0 (no) Sulfonamider og deres anvendelse
NO964583D0 (no) Lettvekts brönnsementsammensetninger og fremgangsmåter
DK0832104T3 (da) Dolastatinderivater, deres fremstilling og anvendelse
DK0832082T3 (da) N-heteroaryl-pyridinsulfonamidderivater og deres anvendelse som endotelinantagonister
NO933434D0 (no) Piperidinderivater, deres fremstilling og anvendelse
DK1019358T3 (da) 3,3-diarylpropylaminer, deres anvendelse og fremstilling
ATE357459T1 (de) Antikörper gegen mensliches il-12
NO20006488D0 (no) Sammensetning og anvendelse
DK0804078T3 (da) Sammensætning og anvendelse deraf
NO981282D0 (no) Calcitriolderivater og deres anvendelser
NO986034D0 (no) Kombinasjoner omfattende VX 478, ZidovudÞn, FTC og/eller 3TC for anvendelse
DE69606414T2 (de) In Gegenwart von Wasser oder Luftfeuchtigkeit härtbare Siliconzusammensetzungen
NO963723L (no) Flytepunktnedsettende tilsetningsstoffer og deres anvendelse
DK60893D0 (da) Piperidinderivater, deres fremstilling og anvendelse
NO933435D0 (no) Piperidinderivater, deres fremstilling og anvendelse
DK278289D0 (da) Ekspressionsvektorer, deres fremstilling og anvendelse til fremstilling af ufusionerede proteiner i mikroorganismer
NO972821D0 (no) 1-C-perfluoralkylglycosider, deres fremstilling og anvendelse
DK0776899T3 (da) Mellemprodukter og deres anvendelse til fremstilling af N,N'-forbundne bisindolylmaleimider
NO986035D0 (no) Kombinasjoner omfattende VX478, zidovudin og/eller 1592U89 for anvendelse i
ATE187643T1 (de) Verringerung von knochenschwund durch antiöstrogen-kombinationen
NO903321D0 (no) Vaate ugarvede huder som er biologisk stabile og fremgangsmaate for deres fremstilling.
DK0434020T3 (da) 2,19-Methylenoxy- og 2,19-methylenthiobroforbundne steroider og deres anvendelse som inhibitorer af aromatase og 19-hydroxylase